PT921804E - Metodo contraceptivo bifasico e conjunto ("kit") compreendendo uma combinacao de uma progestina e um estrogenio - Google Patents

Metodo contraceptivo bifasico e conjunto ("kit") compreendendo uma combinacao de uma progestina e um estrogenio

Info

Publication number
PT921804E
PT921804E PT97938011T PT97938011T PT921804E PT 921804 E PT921804 E PT 921804E PT 97938011 T PT97938011 T PT 97938011T PT 97938011 T PT97938011 T PT 97938011T PT 921804 E PT921804 E PT 921804E
Authority
PT
Portugal
Prior art keywords
daily dosage
combination
phase
progestin
estrogen
Prior art date
Application number
PT97938011T
Other languages
English (en)
Inventor
Michael Jay Gast
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of PT921804E publication Critical patent/PT921804E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Communication Control (AREA)
PT97938011T 1996-07-26 1997-07-23 Metodo contraceptivo bifasico e conjunto ("kit") compreendendo uma combinacao de uma progestina e um estrogenio PT921804E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69042296A 1996-07-26 1996-07-26

Publications (1)

Publication Number Publication Date
PT921804E true PT921804E (pt) 2004-01-30

Family

ID=24772384

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97938011T PT921804E (pt) 1996-07-26 1997-07-23 Metodo contraceptivo bifasico e conjunto ("kit") compreendendo uma combinacao de uma progestina e um estrogenio

Country Status (12)

Country Link
EP (1) EP0921804B1 (pt)
JP (1) JP2000515889A (pt)
KR (1) KR20000029536A (pt)
CN (1) CN1186023C (pt)
AT (1) ATE249222T1 (pt)
AU (1) AU4043597A (pt)
CA (1) CA2261748A1 (pt)
DE (1) DE69724796T2 (pt)
DK (1) DK0921804T3 (pt)
ES (1) ES2205252T3 (pt)
PT (1) PT921804E (pt)
WO (1) WO1998004265A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4344462C2 (de) 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
FR2754179B1 (fr) 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
FR2801218B1 (fr) * 1999-11-23 2001-12-28 Hoechst Marion Roussel Inc Compositions pharmaceutiques comprenant de la trimegestone, leurs procedes de preparation ainsi que le conditionnement primaire les renfermant
EP1535618A1 (en) * 2003-11-26 2005-06-01 Schering Aktiengesellschaft Pharmaceutical preparation for continuous hormonal treatment over a period of longer than 21-28 days comprising two estrogen and/or progestin compositions
DE102004019743B4 (de) 2004-04-20 2008-11-27 Bayer Schering Pharma Aktiengesellschaft Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens
DE102005034498A1 (de) * 2005-07-20 2007-01-25 Grünenthal GmbH Orale Kontrazeption mit Trimegeston
ATE424828T1 (de) * 2005-10-13 2009-03-15 Bayer Schering Pharma Ag Verwendung von estradiolvalerat in kombination mit dienogest zur oralen therapie der dysfunktionellen uterinen blutung in einheit mit einer oralen kontrazeption
EP1930010A1 (de) 2006-10-20 2008-06-11 Bayer Schering Pharma Aktiengesellschaft Verwendung von Estradiolvalerat oder 17ß-Estradiol in Kombination mit Dienogest zur oralen Therapie für den Erhalt und/oder die Steigerung der weiblichen Libido
WO2008049172A1 (en) * 2006-10-27 2008-05-02 Vision Biosystems Limited A method and apparatus for dispensing substrates

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4308406C1 (de) * 1993-03-12 1994-06-16 Jenapharm Gmbh Kombinationspräparat zur Kontrazeption
DE4344462C2 (de) * 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung

Also Published As

Publication number Publication date
DE69724796D1 (de) 2003-10-16
ATE249222T1 (de) 2003-09-15
CN1186023C (zh) 2005-01-26
CN1226167A (zh) 1999-08-18
CA2261748A1 (en) 1998-02-05
EP0921804B1 (en) 2003-09-10
EP0921804A1 (en) 1999-06-16
JP2000515889A (ja) 2000-11-28
WO1998004265A1 (en) 1998-02-05
AU4043597A (en) 1998-02-20
DE69724796T2 (de) 2004-07-01
ES2205252T3 (es) 2004-05-01
DK0921804T3 (da) 2003-11-24
KR20000029536A (ko) 2000-05-25

Similar Documents

Publication Publication Date Title
BR9710566A (pt) M-todo anticoncepcional monof sico e um kit compreendendo uma combina-Æo de uma progestina e estrog-nio
DK365887D0 (da) Kombinationsdoseringsform til hormonbehandling af kvinder i prae-menopausen
AU645637B2 (en) Contraceptive regimen
CY1105276T1 (el) Τριφασικο στοματικο αντισυλληπτικο
WO1998004246A3 (en) Triphasic contraceptive method and kit comprising a combination of a progestin and estrogen
DK0917466T3 (da) Oralt antikonceptionsmiddel
PT921804E (pt) Metodo contraceptivo bifasico e conjunto ("kit") compreendendo uma combinacao de uma progestina e um estrogenio